A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapy

✍ Scribed by Sculier, J.P.; Berghmans, T.; Lafitte, J.J.; Richez, M.; Recloux, P.; Van Cutsem, O.; Ninane, V.; Mommen, P.; Paesmans, M.; Klastersky, J.

• Book ID: 118570832
• Publisher: Elsevier Science
• Year: 2002
• Tongue: English
• Weight: 98 KB
• Volume: 37
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/s0169-5002(02)00037-5